Cross resistance and collateral sensitivity between cytotoxic drugs and radiation in two human bladder cell lines

Radiotherapy and Oncology

Volumn 39, Issue 1, 1996, Pages 81-86

  Pauwels, Olivier ^a   Gozy, Michel ^b   Van Houtte, Paul ^c   Pasteels, Jean Lambert ^a   Atassi, Ghanem ^a   Kiss, Robert ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b INSTITUT CURIE   (France)

^c JULES BORDET INSTITUTE   (Belgium)

Author keywords

Chemoresistance; Cross resistance; In vitro; Radioresistance

Indexed keywords

ANTINEOPLASTIC AGENT; DOXORUBICIN; NAVELBINE; TETRAZOLIUM;

ARTICLE; BLADDER CANCER; CONTROLLED STUDY; CROSS RESISTANCE; DRUG RESISTANCE; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; RADIOSENSITIVITY; TUMOR CELL LINE;

EID: 0030010211     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/0167-8140(95)01696-1     Document Type: Article

References (25)

1. Bubenik, J., Baresova, M., Viklicky, V., Jakoubkova, J., Sainerova, S. and Donner, J. Established cell line of urinary bladder carcinoma (T24) containing tumour specific antigen. Int. J. Cancer 11: 765-773, 1973.
2. Budel, V., Pauwels, O., Francisco, J., Gasperin, P., Pasteels, J.L. and Kiss, R. Characterization of chemotherapy-induced morphonuclear modifications in the P388 leukaemia and the MXT mamary tumour models of the mouse. J. Cancer Res. Clin. Oncol. 121: 89-97, 1995.
3. Carter, S.K. Adriamycin. A review. J. Natl. Cancer Inst. 55: 1265-1274, 1975.
4. Cazin, J.L., Gosselin, P., Cappelaere, P., Robert, J. and Demaille, A. Drug resistance in oncology: from concepts to applications. J. Cancer Res. Clin. Oncol. 119: 79-86, 1992.
5. Delville, J.P., Pradier, O., Pauwels, O., Van Onderbergen, A., Kiss, R., Feremans, W. and Capel, P. A comparative study of multidrug resistance evaluated by means of the quantitative immunohistochemical detection of P-glycoprotein and the functional release of rhodamine 123. Am. J. Hematol. 49: 183-193, 1995
6. De Pooler, C.M.J., Scalliet, P.G., Elst, H.J., Huybrechts, J.J., Gheuens, E.E.O., Van Oosterom, A.T., Fichtinger-Schepman, A.M.J. and De Bruijn, E.A. Resistance patterns between cis-diamminedichloroplatinum (II) and ionizing radiation. Cancer Res. 51: 4523-4527, 1991.
7. Francisco, J., Pauwels, O., Gasperin, P., Van Houtte, P., Pasteels, J.L. and Kiss, R. Computer-assisted morphonuclear characterization of radiotherapy-induced effects in MXT mouse mammary adenocarcinomas surviving earlier radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 32: 409-419, 1995.
8. Gasperin, P., Gozy, M., Pauwels, O., Frühling, J., Van Houtte, P., Pasteels, J.L. and Kiss, R. Monitoring of radiotherapy-induced morphonuclear modifications in the MXT mouse mammary carcinoma by means of digital cell image analysis. Int. J. Radiat. Oncol. Biol. Phys. 22: 979-987, 1992.
9. Gozy, M., Pauwels, O., Gasperin, P., Pasteels, J.L., Van Houtte, P. and Kiss, R. in vitro charaterization of radiotherapy-induced morphonuclear modifications on chemosensitive as opposed to chemoresistant neoplastic cells. Int. J. Radiat. Oncol. Biol. Phys. 27: 83-91, 1993.
10. Hellman, S. Principles of radiation therapy. In: Cancer Principles and Practice of Oncology, Volume 1, pp. 248-275. Editors: V.T. DeVita, S. Hellman and S.A. Rosenberg. Lippincott Company, Philadelphia, 1993.
11. Hill, B.T. Differing patterns of cross resistance resulting from exposures to specific antitumour drugs or to radiation in vitro. Cytotechnology 12: 265-288, 1993.
12. Hill, B.T., Deuchars, K., Hosking, L.K., Ling, V. and Whelan, R.D.H. Overexpression of P-glycoprotein in mammalian tumor cell lines after fractionated X-irradiation in vitro. J. Natl. Cancer Inst. 82: 607-612, 1990.
13. Hopwood, L.E. and Moulder, J.E. Radiation induction of drug resistance in RIF-1 tumors and tumor cells. Radiat. Res. 120: 251-266, 1989.
14. Jäckel, M., Tausch-Treml, R. and Köpf-Maier, P. Effect of acquired cisplatin resistance on the response of a xenografted human hypopharynx carcinoma to concurrent radiochemotherapy with cisplatin. Laryngoscope 104: 329-334, 1994.
15. Labarre, J.F. Natural polyamines linked cyclophosphazenes. Attemps as the production of more selective antitumorals. Topic Curr. Chem. 129: 173-260, 1985.
16. Louie, K.G., Behrens, B.C., Kinsella, T.J., Hamilton, T.C., Grotzinger, K.R., McKoy, W.M., Winker, M.A. and Ozols, R.F. Radiation survival parameters of antineoplastic drug-sensitive and-resistant human ovarian cancer cell lines and their modification by buthionine sulfoximine. Cancer Res. 45: 2110-2115, 1985.
17. McClean, S., Hosking, L.K. and Hill, B.T. Expression of P-glycoprotein-mediated drug resistance in CHO cells surviving a single X-ray dose of 30 Gy. Int. J. Radiat. Biol. 63: 765-773, 1993.
18. Mosmann, T. Rapid colorimetric assay for cellular growth and survival application to proliferation and cytotoxicity assays. J. Immunol. Methods 65: 55-63, 1983.
19. Oshita, F., Fujiwara, Y. and Saijo, N. Radiation sensitivities in various anticancer drug-resistant human lung cancer cell lines and mechanism of radiation cross resistance in a cisplatin-resistant cell line. J. Cancer Res. Clin. Oncol. 119: 28-34, 1992.
20. O'Toole, C., Price, Z.H., Ohnuki, Y. and Unsgaard, B. Ultra-structure, kariology and immunology of a cell line originated from a human transitional-cell carcinoma. Br. J. Cancer 38: 64-76, 1978.
21. Pauwels, O. and Kiss, R. Digital morphonuclear analyses of sensitive versus resistant neoplastic cells to vinca-alkaloid, alkylating and intercalating drugs. Cytometry 12: 388-397, 1991.
22. Pauwels, O. and Kiss, R. Monitoring of chemotherapy-induced morphonuclear modifications by means of digital cell-image analysis. J. Cancer Res. Clin. Oncol. 119: 533-540, 1993.
23. Pauwels, O. and Kiss, R. Characterization of cross-resistance expressed by 12 chemoresistant cancer cell lines to 15 antineoplastic agents. Cell. Pharmacol. 1: 279-285, 1994.
24. Potier, P. The syntesis of Navelbine® prototype of a new series of vinblastine derivatives. Sem. Oncol. 16 (suppl. 4): 2-4, 1989.
25. Weichselbaum, R.R., Dahlberg, W., Beckett, M., Karrison, T., Miller, D., Clark, J. and Ervin, T.J. Radiation-resistant and repair-proficient human tumor cells may be associated with radiotherapy failure in head- and neck cancer patients. Proc. Natl. Acad. Sci. USA. 83: 2684-2688, 1986.